Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X0VH
|
|||
| Drug Name |
PMID25656651-Compound-28a
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ZHANG, Dawei
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C31H31F4N7O
|
|||
| Canonical SMILES |
CCN1CCN(CC1)CC2=C(C=C(C=C2)C(=O)NC3=CC(=C(C(=C3)F)C)NC4=NC=CC(=N4)C5=CN=CC=C5)C(F)(F)F
|
|||
| InChI |
1S/C31H31F4N7O/c1-3-41-11-13-42(14-12-41)19-23-7-6-21(15-25(23)31(33,34)35)29(43)38-24-16-26(32)20(2)28(17-24)40-30-37-10-8-27(39-30)22-5-4-9-36-18-22/h4-10,15-18H,3,11-14,19H2,1-2H3,(H,38,43)(H,37,39,40)
|
|||
| InChIKey |
CQBGILGFZXYQMT-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.